|
Oz, H S; Hughes, W T (2000) Search for Pneumocystis carinii DNA in upper and lower respiratory tract of humans. Diagn Microbiol Infect Dis 37:161-4
|
|
Eichelberger, M C; Suresh, P; Rehg, J E (2000) Protection from Cryptosporidium parvum infection by gammadelta T cells in mice that lack alphabeta T cells. Comp Med 50:270-6
|
|
Oz, H S; Hughes, W T; Rehg, J E (1999) Rat model for dual opportunistic pathogen prophylaxis: Cryptosporidium parvum and Pneumocystis carinii. Lab Anim Sci 49:331-4
|
|
Suresh, P; Rehg, J E (1996) Comparative evaluation of several techniques for purification of Cryptosporidium parvum oocysts from rat feces. J Clin Microbiol 34:38-40
|
|
Rehg, J E (1996) Effect of interferon-gamma in experimental Cryptosporidium parvum infection. J Infect Dis 174:229-32
|
|
Rehg, J E (1996) Effect of diethyldithiocarbamate on Cryptosporidium parvum infection in immunosuppressed rats. J Parasitol 82:158-62
|
|
Rehg, J E (1995) The activity of halofuginone in immunosuppressed rats infected with Cryptosporidium parvum. J Antimicrob Chemother 35:391-7
|
|
Rehg, J E (1994) A comparison of anticryptosporidial activity of paromomycin with that of other aminoglycosides and azithromycin in immunosuppressed rats. J Infect Dis 170:934-8
|
|
Rehg, J (1994) New potential therapies for cryptosporidiosis: an analysis of variables affecting drug efficacy. Folia Parasitol (Praha) 41:23-6
|
|
Rehg, J E (1993) Anticryptosporidial activity of lasalocid and other ionophorous antibiotics in immunosuppressed rats. J Infect Dis 168:1566-9
|
